Cost-effectiveness analysis of SARS-CoV-2 infection prevention strategies including pre-endoscopic virus testing and use of high risk personal protective equipment.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 21 10 2020
medline: 4 2 2021
entrez: 20 10 2020
Statut: ppublish

Résumé

Infection prevention strategies to protect healthcare workers in endoscopy units during the post-peak phase of the COVID-19 pandemic are currently under intense discussion. In this paper, the cost-effectiveness of routine pre-endoscopy testing and high risk personal protective equipment (PPE) is addressed. A model based on theoretical assumptions of 10 000 asymptomatic patients presenting to a high volume center was created. Incremental cost-effectiveness ratios (ICERs) and absolute costs per endoscopy were calculated using a Monte Carlo simulation. ICER values for universal testing decreased with increasing prevalence rates. For higher prevalence rates (≥ 1 %), ICER values were lowest for routine pre-endoscopy testing coupled with use of high risk PPE, while cost per endoscopy was lowest for routine use of high risk PPE without universal testing. In general, routine pre-endoscopy testing combined with high risk PPE becomes more cost-effective with rising prevalence rates of COVID-19.

Sections du résumé

BACKGROUND
Infection prevention strategies to protect healthcare workers in endoscopy units during the post-peak phase of the COVID-19 pandemic are currently under intense discussion. In this paper, the cost-effectiveness of routine pre-endoscopy testing and high risk personal protective equipment (PPE) is addressed.
METHOD
A model based on theoretical assumptions of 10 000 asymptomatic patients presenting to a high volume center was created. Incremental cost-effectiveness ratios (ICERs) and absolute costs per endoscopy were calculated using a Monte Carlo simulation.
RESULTS
ICER values for universal testing decreased with increasing prevalence rates. For higher prevalence rates (≥ 1 %), ICER values were lowest for routine pre-endoscopy testing coupled with use of high risk PPE, while cost per endoscopy was lowest for routine use of high risk PPE without universal testing.
CONCLUSION
In general, routine pre-endoscopy testing combined with high risk PPE becomes more cost-effective with rising prevalence rates of COVID-19.

Identifiants

pubmed: 33080647
doi: 10.1055/a-1294-0427
pmc: PMC7869042
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-161

Commentaires et corrections

Type : CommentIn

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Références

N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Int J Infect Dis. 2020 May;94:154-155
pubmed: 32179137
Gastrointest Endosc. 2020 Sep;92(3):735-742
pubmed: 32360301
Endoscopy. 2020 Oct;52(10):891-898
pubmed: 32643767
Gastrointest Endosc. 2020 Aug;92(2):435-439
pubmed: 32234312
Front Med (Lausanne). 2020 May 08;7:225
pubmed: 32574326
J Clin Virol. 2020 Jul;128:104428
pubmed: 32434706
Gastrointest Endosc. 2020 Sep;92(3):524-534.e6
pubmed: 32360302
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
Gastrointest Endosc. 2020 Sep;92(3):743-747.e1
pubmed: 32437712
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930

Auteurs

Alanna Ebigbo (A)

Department of Gastroenterology, Universitätsklinikum Augsburg, Augsburg, Germany.

Christoph Römmele (C)

Department of Gastroenterology, Universitätsklinikum Augsburg, Augsburg, Germany.

Christina Bartenschlager (C)

Chair of Health Care Operations/Health Information Management (UNIKA-T), Faculty of Business and Economics, University of Augsburg, Augsburg, Germany.

Selin Temizel (S)

Department of Hygiene and Environmental Medicine, Universitätsklinikum Augsburg, Augsburg, Germany.

Elisabeth Kling (E)

Department of Laboratory Medicine and Microbiology, Universitätsklinikum Augsburg, Augsburg, Germany.

Jens Brunner (J)

Chair of Health Care Operations/Health Information Management (UNIKA-T), Faculty of Business and Economics, University of Augsburg, Augsburg, Germany.

Helmut Messmann (H)

Department of Gastroenterology, Universitätsklinikum Augsburg, Augsburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH